Correction: Review of the novel antifungal drug olorofim (F901318).
作者信息
Vanbiervliet Yuri, Nieuwenhuyse Tine Van, Aerts Robina, Lagrou Katrien, Spriet Isabel, Maertens Johan
机构信息
Department of Haematology, Department of Microbiology, Immunology and Transplantation, University Hospitals Leuven, KU Leuven, Herestraat 49, Leuven, 3000, Belgium.
Pharmacy Department, University Hospitals Leuven, Herestraat 49, Louvain, 3000, Belgium.
出版信息
BMC Infect Dis. 2024 Dec 12;24(1):1395. doi: 10.1186/s12879-024-10295-2.
Abstract
摘要
相似文献
1
Correction: Review of the novel antifungal drug olorofim (F901318).更正：新型抗真菌药物奥洛菲姆（F901318）综述。
BMC Infect Dis. 2024 Dec 12;24(1):1395. doi: 10.1186/s12879-024-10295-2.
2
Effect of the Novel Antifungal Drug F901318 (Olorofim) on Growth and Viability of Aspergillus fumigatus.新型抗真菌药物 F901318（奥利伏霉素）对烟曲霉生长和活力的影响。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00231-18. Print 2018 Aug.
3
Review of the novel antifungal drug olorofim (F901318).新型抗真菌药物奥利伏非姆（F901318）的综述。
BMC Infect Dis. 2024 Nov 7;24(1):1256. doi: 10.1186/s12879-024-10143-3.
4
Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and Serum.一种可靠且易于使用的液相色谱-串联质谱法测定人血浆和血清中新型抗真菌药物奥洛福米（F901318）的方法。
Antimicrob Agents Chemother. 2018 Oct 24;62(11). doi: 10.1128/AAC.01356-18. Print 2018 Nov.
5
In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents.新型抗真菌药物奥洛罗芬对丝状真菌的体外活性及与其他八种抗真菌药物的比较
J Fungi (Basel). 2021 May 12;7(5):378. doi: 10.3390/jof7050378.
6
Efficacy of Olorofim (F901318) against , , and in Murine Models of Profound Neutropenia and Chronic Granulomatous Disease.氟罗福司汀（F901318）在严重中性粒细胞减少症和慢性肉芽肿病的小鼠模型中对 、 、 的疗效。
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.00129-19. Print 2019 Jun.
7
In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies.微量肉汤稀释法和 CLSI 方法检测olorofim（F901318）对曲霉属隐种临床分离株的体外活性。
J Antimicrob Chemother. 2019 Jun 1;74(6):1586-1590. doi: 10.1093/jac/dkz078.
8
In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus.奥拉罗芬（F901318）对赛多孢子菌属和拉氏菌属真菌以及对多育镰刀菌、皮炎外瓶霉和耐唑类烟曲霉的体外活性。
Int J Antimicrob Agents. 2020 Sep;56(3):106105. doi: 10.1016/j.ijantimicag.2020.106105. Epub 2020 Jul 25.
9
Review of the Novel Investigational Antifungal Olorofim.新型研究性抗真菌药物奥洛罗芬的综述
J Fungi (Basel). 2020 Jul 30;6(3):122. doi: 10.3390/jof6030122.
10
Potency of olorofim (F901318) compared to contemporary antifungal agents against clinical isolates, and review of azole resistance phenotype and genotype epidemiology in China.奥洛菲姆（F901318）与当代抗真菌药物对临床分离株的抗菌活性比较，以及中国唑类耐药表型和基因型流行病学综述
Antimicrob Agents Chemother. 2023 May 1;65(5). doi: 10.1128/AAC.02546-20. Epub 2021 Mar 8.
引用本文的文献
1
Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects.新一代抗真菌药物：作用机制、疗效及临床前景。
Acta Pharm Sin B. 2025 Aug;15(8):3852-3887. doi: 10.1016/j.apsb.2025.06.013. Epub 2025 Jun 23.
2
Discovery of Novel Inhibitors of DHODH via Virtual Screening, MD Simulation, and In Vitro Activity Assay.通过虚拟筛选、分子动力学模拟和体外活性测定发现二氢乳清酸脱氢酶的新型抑制剂
Molecules. 2025 Jun 16;30(12):2607. doi: 10.3390/molecules30122607.
本文引用的文献
1
Review of the novel antifungal drug olorofim (F901318).新型抗真菌药物奥利伏非姆（F901318）的综述。
BMC Infect Dis. 2024 Nov 7;24(1):1256. doi: 10.1186/s12879-024-10143-3.
Zotero 插件